glp 1 lilly Oral GLP-1 Orforglipron Is Approved for Obesity Lilly GLP-1 analogues - Glucagon.com

The FDA issued over 80 warning letters to companies marketing compounded GLP-1 products with misleading claims in 2025-2026

First-trimester vaginal bleeding and complications later in pregnancy

Wahdati A, Lindner A, Sommer H

private insurers and employer plans often treat GLP-1 injections as specialty medications , subject to tight utilization management

For CJC-1295 specifically, the most direct human evidence is endocrine: increased GH and IGF-1, particularly with the DAC-modified analog. Why it matters: CJC-1295 is relevant to body-composition research because it activates a pathway involved in lean tissue signaling, fat metabolism, and tissue remodeling